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Abstract
The cervix undergoes marked mechanical trauma during delivery of the baby at birth. As such, a 
timely and complete tissue repair postpartum is necessary to prevent obstetrical complications, 
such as cervicitis, ectropion, hemorrhage, repeated miscarriages or abortions and possibly pre- 
term labor and malignancies. However, our knowledge of normal cervical repair is currently 
incomplete and factors that influence repair are unclear. Here, we characterize the 
morphological and angiogenic profile of postpartum repair in mice cervix during the first 48 h 
of postpartum. The key findings presented here are: (1) cervical epithelial folds and size are 
diminished during the first 48 h of postpartum repair, (2) hypoxic inducible factor 1a, vascular 
endothelial growth factor (VEGF), and VEGF receptor 1 expression are pronounced early in 
postpartum cervical repair, and (3) VEGF receptor 2 gene and protein expressions are variable. 
We conclude that postpartum cervical repair involves gross and microscopic changes and is 
linked to expression of angiogenic factors. Future studies will assess the suitability of these 
factors, identified in the present study, as potential markers for determining the phase of 
postpartum cervical repair in obstetrical complications, such as cervical lacerations.
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Introduction
The cervix undergoes marked changes during pregnancy, as
well as significant trauma during normal vaginal delivery of
the baby at birth (parturition) and immediately postpartum
(after birth) (Timmons et al. 2010). As such, a timely and
complete postpartum tissue repair is necessary to prevent ob-
stetrical complications, such as cervicitis, ectropion, hemor-
rhage, repeated miscarriages or abortions and, possibly, pre-
term labor and malignancies (Fahmy et al. 1991). For in-
stance, during pregnancy, the cervix has to contain and with-
stand an ever increasing gravitational force exerted by the
rapidly growing fetus in order to ensure that it (the fetus) is
held in utero (Timmons et al. 2010), whereas at parturition,
under the intense force of the contracting uterus, the ripened
cervical tissue is forced to expand and dilate to ultimately
allow passage of the fetus through the birth canal
(Mahendroo 2012). Immediately following these dramatic
mechanical tissue Bassaults^, the cervix undergoes an exten-
sive postpartum reconstruction and healing phase that restores
it (the cervix) to its non-pliable non-pregnant state (Timmons
and Mahendroo 2007). Collectively, these changes (gestation-
al and postpartum) are termed cervical remodeling (CR),
which is divided into four distinct yet overlapping phases,
namely softening, ripening, dilation and postpartum repair
(Read et al. 2007; Word et al. 2007). To date, most of the
studies have focused on the first three phases of CR, almost
at the exclusion of postpartum repair.
Postpartum repair consists of a set of complex biological
processes that ultimately restores the cervix to its original non-
pregnant state, and thus ensures normal cervical function for
subsequent pregnancies (Timmons et al. 2010; Mahendroo
2012). This final phase of CR is generally characterized as
an inflammatory and wound-healing response (Timmons and
Mahendroo 2007; Bauer et al. 2009), as demonstrated by
studies that utilized gene microarrays. These studies have
shown that a variety of factors, including pro-inflammatory
factors, metalloproteases, proteins involved in extracellular
matrix (ECM) synthesis, and genes governing epithelial dif-
ferentiation pathways are all up-regulated postpartum
(Timmons and Mahendroo 2007; Gonzalez et al. 2009).
Immune cells, including neutrophils, eosinophils, and both
M1 and M2 macrophages, have all been shown to increase
postpartum compared to earlier phases of remodeling
(Timmons et al. 2009, 2010; Mahendroo 2012). This inflam-
matory response could serve to promote repair of the cervix
after parturition and/or serve a protective role of the birth canal
against environmental hazards, such as infection (Gonzalez
et al. 2009). Because inflammation and wound healing are
intricately linked to vascular events, factors that regulate this
process, notably vascular endothelial growth factor (VEGF)
(Nguyen et al. 2012), also likely influence postpartum cervical
repair. Of note, VEGF is expressed in normal, pregnant and
cancerous cervices in rodents and humans.
The importance of the role of VEGF in wound healing has
been well documented and characterized (Galiano et al. 2004;
Mowa et al. 2008a; Alberts et al. 2008; Bao et al. 2009).
VEGF controls wound healing by inducing various vascular
processes, including angiogenesis (capillary growth), vaso-
permeability, and recruitment of immune cells, as well as ep-
ithelization and collagen deposition (Bao et al. 2009), the hall-
mark of the healing response (Mahendroo 2012). For instance,
induction of capillary growth during wound repair meets the
growing demands for oxygen and nutrients, as well as remov-
al of waste products (Alberts et al. 2008). Indeed, inhibition of
angiogenesis impairs wound healing, demonstrating the vital
role of VEGF in this (healing) process (Galiano et al. 2004;
Bao et al. 2009). Factors that induce VEGF expression during
wound healing include growth factors (transforming growth
factor, hepatocyte growth factor, keratinocyte growth factor,
etc.), pro-inflammatory cytokines, such as interleukin-1 (IL-1)
and tumor necrosis factor alpha (TNFα), and, notably, hypox-
ia, i.e., low oxygen (Eming and Krieg 2006). Cells in a hyp-
oxic environment will accumulate the intracellular transcrip-
tion factor, hypoxia inducible factor-1 alpha (HIF-1α), which
is the most potent inducer of VEGF transcription (Majmundar
et al. 2010). Following injury, VEGF is first secreted by hyp-
oxic cells and will establish a gradient of VEGF, mirroring the
gradient of hypoxia (Alberts et al. 2008). Activated platelets,
and immune cells, i.e. macrophages and neutrophils, express
VEGF receptor 1 (VEGFR1) and respond chemotactically to
VEGF, and will migrate towards the VEGF source at the site
of injury and/or hypoxia (Bao et al. 2009; Eming and Krieg
2006). Macrophages and neutrophils will in turn stimulate
angiogenesis by further secreting VEGF and TNFα that will
also stimulate VEGF production in keratinocytes and fibro-
blasts (Bao et al. 2009). Although the role of VEGF in the
cervical events during pregnancy has been studied (Nguyen
et al. 2012; Eming and Krieg 2006; Mowa et al. 2004, 2008b;
Donnelly et al. 2013), to date, no study has examined its role,
if any, in postpartum cervical repair.
The presence and profile of VEGF and its key tyrosine
kinase receptors have been characterized in the uterine cervix
of rodents (mice and rats), and human and VEGF-related genes
in rats have been delineated using DNAmicroarray analysis in
pregnant and non-pregnant conditions (Nguyen et al. 2012;
Mowa et al. 2004, 2008a, b; Donnelly et al. 2013; and unpub-
lished data). The effects of VEGF are largely mediated by
VEGFR-1 (or fms-related tyrosine kinase-1, flt-1) and VEGF
R-2, which have different signaling properties and are largely
expressed by endothelial cells (Mowa et al. 2004).
Since postpartum repair is considered a pro-inflammatory
wound healing response (Mahendroo 2012; Timmons and
Mahendroo 2007; Bao et al. 2009), and VEGF is known to
induce inflammation in the cervix (Nguyen et al. 2012) and
plays roles in: (1) cervical remodeling (CR) during pregnancy
in rodents (Mowa et al. 2008b; Donnelly et al. 2013), and (2)
general wound healing (Bao et al. 2009; Eming and Krieg
2006), here we speculate that VEGF plays a role in the post-
partum repair phase of CR. In this study, we sought to deter-
mine: (1) the gross morphological changes of the postpartum
cervix, and (2) the expression patterns of HIF-1α, VEGF, and
the VEGF receptors (VEGFR-1 and VEGFR-2), during the
first 2 days in mice.
Materials and methods
Animals and postpartum time intervals
Pregnant mice (C57BL6/129SvEv; Charles River, n=3~5 per
technique of each time-point, except for H&E staining and
confocal immunofluorescence, where n=1) were used in the
present study during the time points specified here: The time
of the first pup was noted as time 0 h and the mothers were
sacrificed at an 8-h interval, after parturition, beginning with
0 h, i.e., 0, 8, 16, 24, 32, 40 and 48 h. The average interval
between the birth of the first and last pup was within 1 h, with
an average litter size between 8–12 pups. All animals were
euthanized by a lethal injection of sodium pentobarbital
(150 mg/kg bw, i.p.) and transcardially perfused with 0.9 %
saline solution. Cervices were carefully harvested under a ste-
reomicroscope, to avoid contamination with vaginal and uter-
ine tissues, and the tissues were then processed and analyzed
accordingly, including using scanning electron and light mi-
croscopy imaging, gene expression analysis using real-time
PCR, and protein expression analysis using Western blot and
confocal immunofluorescence. All animals were housed un-
der the following conditions: constant room temperature (RT);
a 12:12-h light:dark cycle, and free access to water and food.
All experiments were performed in accordance with the
Institutional Animal Care and Use Committee (IACUC) of
Appalachian State University and the NIH guidelines (NIH
publication number 86-23), with efforts made to minimize
both number of animals used and animal suffering.
Scanning electron microscopy (SEM)
SEM was employed to observe the surface of cervical epithe-
lia and any changes occurring during the postpartum period.
Harvested cervices were immediately immersed in a 2.5 %
glutaraldehyde, 0.1 M phosphate buffer solution (PBS) and
the tissues were then dehydrated in a graded series of ethanol
and dried using a critical point drying apparatus (Polaron
Instruments, Laughton, East Sussex, UK). The dry samples
weremounted on aluminum stubs with carbon adhesive paper,
sputter-coated in gold and viewed with the SEM (FEI,
Hillsboro, OR, USA). The cervical epithelium was evaluated
for various features, including, but not limited to, involutions,
tissue size, overall appearance of cells, presence of macro-
phages and paracellular spaces.
Confocal immunofluorescence
Confocal immunofluorescence was employed to complement
Western blot data of the proteins of interest (VEGF, VEGF
receptors, HIF-1α), as well as determine their cellular locali-
zation in the cervix.
Harvested cervices were immersed in a 10 % formalin
(pH 7.2) aqueous solution. The tissues were fixed in formalin
at 4 °C for 3–4 days and then transferred into saturated sucrose
dissolved in 0.1 M PBS, for at least 2 days prior to sectioning
(12 μm) with the Cryostat (Leica, Buffalo Grove, IL, USA) at
−30 °C. After sectioning, the slides were either stained imme-
diately or stored at –20 °C until staining. For staining, the
sections were initially incubated with 10% normal goat serum
in 0.1 M PBS for 20 min at RT in order to block non-specific
protein binding. Next, the sections were washed 3 times in
0.1 M PBS and then incubated overnight at 4 °C with diluted
primary antibodies of interest at 0.5 μg/mL (Santa Cruz
Biotech, Santa Cruz, CA, USA). The next day, the sections
were washed 3 times with 0.1 M PBS Buffer followed imme-
diately by incubation in diluted fluoro-tagged secondary anti-
body at 0.5 μg/mL (Santa Cruz Biotech) for 1 h at RT.
Thereafter, the sections were washed 3 times with 0.1 M
PBS, counterstained with 5 μMSytoxGreen™, mounted with
aqueous Ultracruz Mounting Medium (Santa Cruz Biotech),
and then examined with a confocal microscope (Carl Zeiss,
Peabody, MA, USA).
Gene expression studies (real time PCR)
To perform gene expression studies, total RNA was first ex-
tracted, reverse-transcribed into cDNA and then amplified.
Harvested cervices were snap-frozen and then either total
RNAwas extracted immediately or the tissues were stored at
−80 °C until processing. Tissues were first homogenized in
Qiazol Lysis reagents (Qiagen, Valencia, CA, USA) and then
total RNAwas extracted using RNeasyMini Kit (Qiagen) and
its quality and quantity determined using the Nanodrop appa-
ratus (Thermo Scientific, Waltham, MA, USA). If of good
quality and quantity, the total RNA (1000 ng) was then reverse
transcribed using a cocktail containing the following: MgCl2,
reverse transcriptase, RT buffer, dNTP, RNase inhibitor,
RNase-free water and random hexamers, in order to generate
an equivalent amount of total cDNA using a thermocycler
(Eppendorf, Hamburg, Germany) at the following settings:
25 °C for 10 min, 42 °C for 2 h, 95 °C for 5 min, and 4 °C
for storage, according to protocol. The cDNAwas then used to
amplify specific gene sequences using real-time PCR ampli-
fication (e.g., VEGF, VEGFR1, VEGFR2, HIF-1α, and
Gus-β as a normalizer) in order to determine the relative ex-
pression of these genes in all the time points during the 48 h
after the onset of parturition. We used commercially pre-
designed and optimized real time PCR probes (Applied
Biosystems, Carlsbad, CA, USA). The PCR reactions were
set up in 96-well plate in a volume of 25 μl per well, with
the following components: 1 μl of cDNA, 12.5 μl of 2×
Taqman Universal PCR Mastermix, 1.25 μl of 20× Assays-
on-demand Gene Mix (e.g. VEGF), and 10.25 μl of RNase-
free water. DNA amplification was performed using the ABI
7300 HT Real-Time PCR machine (Applied Biosystems.
Carlsbad, CA, USA) with the GeneAmp 7300 HT sequence
detection system software (Perkin-Elmer, Waltham, MA,
USA), with the settings as follows: 95 °C for 10 min, and then
40 cycles of 95 °C for 15 s, and 60 °C for 60 s.
Western blot analysis
Western blot analysis was used to confirm relative amounts of
the proteins of interest, at the tissue level.
Harvested cervices were snap-frozen and stored at −80 °C
until processing. Total protein was extracted using the protein
inhibitor cocktail and Cell Lysis buffer (Sigma Aldrich, St.
Louis, MO, USA), and quantified with a bicinchoninic acid
(BCA) assay (Thermo Scientific). Next, 10 μg of protein sam-
ples, along with a set of standard protein ladders (Bio-Rad,
Hercules, CA, USA), were loaded on a 4-12 % Bis-Tris Gel
(Invitrogen, Waltham, MA, USA). The gel was electropho-
resed at 75 V until the dye was close to the bottom of the
gel. Thereafter, the protein was transferred to a PVDF mem-
brane using the iBlot apparatus (Invitrogen, Waltham, MA,
USA), and the membrane was incubated overnight with
Blotto (5 % dehydrated milk in Tris Buffered Saline with
Tween) solution at 4 °C. The following day, the membrane
was incubated with the diluted primary antibody dissolved in
Blotto (Santa Cruz Biotech), and left to incubate overnight on
a shaker at RT. Thereafter, the membrane was washed three
times in 1× TBST for 20 min, after which the membrane was
incubated with the diluted secondary antibody, i.e., donkey
anti-rabbit IgG HRP conjugated and StrepTactin HRP anti-
bodies (Santa Cruz Biotech) for 1 h at RT on a shaker. The
membrane was then washed three times with 1× TBST and
one wash with 1× TBS. Horseradish peroxidase solution (Bio-
Rad) was added to the membrane for 5 min and the excess
solution was dripped off. The membranes were then exposed
to x-ray film (GE, Fairfield, CT, USA) in a dark room for an
optimal period (~30 s–1 min), and the film was developed and
analyzed for presence of the target proteins (VEGF, VEGFR1,
VEGFR-2, HIF-1α, and β actin as a normalizer). The densi-
tometry was quantified using ImageJ software (NIH,
Bethesda, MD, USA).
Statistical analysis
Data for western blot and real-time PCR analyses were ana-
lyzed using Student's t test and ANOVA, followed by
Scheffe's F test for multiple comparisons. P values of<0.05
were considered to be statistically significant.
Results
The murine cervix undergoes pronounced morphological
changes during the first 48 h postpartum
SEM analysis of cervices obtained from mice at 0, 24, and
48 h postpartum displayed distinct morphological features at
the time points of interest (Fig. 1). At 0 h, the cervical epithe-
lium displayed folds (Fig. 1a, b) and micro-folds (Fig. 1c, d),
as well as less prominent epithelial cell borders, compared to
both 24- and 48-h postpartum. A layer of unidentified extra-
cellular matrix or cell debris appeared at 24 h postpartum
(Fig. 1g, h), but disappeared by 48 h postpartum. At both
24- and 48-h postpartum, the presence of Bpits^ or gaps in
the cervical epithelium was observed and the cell–cell borders
were more pronounced than at 0 h (Fig. 1f, g, j, k). In order to
further characterize the morphological changes of the postpar-
tum cervix, we performed H&E staining, which revealed
folded cervical epithelium at 0 h PP (Fig. 2a). At 24 h PP,
the layer of unidentified cellular debris reported earlier under
SEM data was observed (Fig. 2d), but not at 48 h PP (Fig. 2g),
consistent with the SEM findings.
Fig. 1 Scanning electron microscopy images of the chronological profile
of postpartum mouse cervical tissue. Low magnification (×50) images
reveal an obvious decrease in size from 0 to 48 h postpartum (PP) (a, e,
i). Cervical epithelial folds, as well as diminished cell–cell borders, were
prominent at 0 h PP at higher magnifications (×500–×5,000). An
unidentified Bcovering^ was observed at 24 h PP, but was absent at 0 h
and had disappeared by 48 h PP. n=3
Gene expression in the murine cervix postpartum
Both VEGFR-1 and VEGFR-2 relative mRNA expressions
were elevated at 0 h postpartum, with approximately 17- and
9-fold increases, respectively, but declined significantly by
48 h postpartum to non-pregnant levels (Fig. 3). VEGF
mRNA expression displayed a 13-fold increase at 0 h
postpartum compared to non-pregnant animals, with
decreased expression at 48 h postpartum relative to
0 h postpartum, but elevated compared to non-
pregnant (Fig. 3). HIF-1α displayed a similar expres-
sion pattern, with an 11-fold increase at 0 h postpartum
compared to non-pregnant state, followed by a signifi-
cant decrease in expression by 48 h postpartum, relative to
0 h postpartum, and only slightly elevated compared to non-
pregnant (Fig. 3).
Fig. 2 Histological images of
mouse postpartum (PP) cervical
tissue, as revealed by H&E
staining. During the hours after
parturition [0 h postpartum (PP)],
the cervical tissue had stromal
cells that appeared more
dispersed, likely due to edema, in
the first 24 h PP (a–d) but
disappeared thereafter (e–g). At
24 and 32 h PP, a layer of
unidentified cellular debris
(arrows) was observed. E cervical
epithelium, L cervical lumen. All
images were taken at ×20. n=1
Fig. 3 Gene expression of
angiogenic factors {VEGF,
VEGF receptors [Flt-1, VEGFR-2
(KDR)] and HIF-1α} in the
postpartum (PP) mouse cervix, as
revealed by real-time PCR
analysis. All the genes of interest
were highly expressed at 0 h PP,
decreasing significantly by 48 h
PP for HIF-1α (*p value=0.02)
(d), VEGFR-2 (*p value=0.008)
(b) and Flt-1 (*p value=0.04) (a)
relative to 0 h. VEGF expression
decreased at 48 h PP but was not
found to be significant and was
several folds above the control
(non-pregnant animals) (c). n=5
Protein expression in the mouse cervix postpartum
VEGF protein expression was found to be at the highest level
at 0 h postpartum, with levels decreasing approximately 2 fold
by 16 h postpartum, followed by a slight decrease for the
remaining time intervals (Fig. 4a). VEGFR-1 was found to
be at its highest expression at 8 h postpartum, with levels
decreasing in the remainder of time intervals, save for a slight
increase at 24 h postpartum, relative to 16 h postpartum
(Fig. 4d). It should be noted that the fold change from the
highest expression (8 h postpartum) to the lowest expression
(48 h) was less than half. In contrast, the other receptor VEGF
R-2, was found to increase steadily during the postpartum
time intervals; with the lowest levels at 0 h, steadily increasing
thereafter and leveling off at 40-48 h postpartum (Fig. 4c).
HIF-1α protein expression pattern was similar to VEGF, i.e.,
it was elevated at 0 h postpartum, and was at its lowest at 48 h
postpartum (Fig. 4b). However, there was an increase in ex-
pression from 16 to 24 h postpartum, remaining elevated at
32 h, and falling off again by 40 h postpartum (Fig. 4b).
Protein expression in the mouse cervix postpartum,
as revealed by confocal immunofluorescence
The highest levels of VEGF were observed at 0 h postpartum
(Fig. 5a), with the lowest levels occurring at 48 h postpartum
(Fig. 5g). The most pronounced expressions of VEGF were
localized on the apical side of the epithelium, regardless of the
time interval or point. It is noteworthy that the expression of
VEGF was readily detected in the layer of cell debris observed
at 24 h postpartum (Fig. 5d) and 32 h postpartum (Fig. 5e).
HIF-1α expression mirrored that of VEGF, i.e., the highest
levels were at 0 h postpartum (Fig. 5a), lowest at 48 h
(Fig. 5g), with expression preferentially localized at the apical
side of the cervical epithelium at each time interval. Also, HIF-
1α expression was similar to VEGF in that it was also readily
expressed in the layer of cell debris at 24 h postpartum
(Fig. 5d) and 32 h postpartum (Fig. 5e). The VEGF receptors
demonstrate different patterns of expression postpartum.
VEGFR-1 expression mirrored that of VEGF and HIF-1α,
with expression clearly at its highest at 0 h postpartum
(Fig. 6a), lowest at 48 h postpartum (Fig. 6g), and localized
to the apical side of the epithelium and in the cell debris layer at
both 24 h postpartum (Fig. 6d) and 32 h postpartum (Fig. 6e).
Overall, intensity of VEGFR-2 immunostaining increased over
time, particularly from 16 h postpartum in epithelia and stro-
mal cells, with the weakest signal appearing between 0-8 h and
slightly diminishing at 48 h (Fig. 7) (Fig. 8).
Discussion
Of the four phases of cervical remodeling, postpartum repair is
the least studied and, to date, there has been no comprehensive
study that has focused exclusively on this fourth and final
phase of cervical remodeling. A comprehensive knowledge
Fig. 4 Chronological expression
patterns of VEGF, HIF-1α, Flt-1,
and VEGFR-2 (KDR) proteins in
postpartum mouse cervix, as
determined by Western blot
analysis. a VEGF protein
expression decreased over time
between 0 and 48 h postpartum
(PP) (*p value=4.56 × 10−8); b
HIF-1α protein expression
decreased between 0 and 16 h but
surged to 8 h levels between 24
and 32 h, and decreased steadily
thereafter, reaching its lowest
levels by 48 h PP (*p value=
3.08 × 10−8); c VEGFR-2 protein
expression pattern was opposed to
that of VEGF, i.e., it steadily
increased over time, plateauing by
40–48 h PP (*p value=0.0005);
and d Flt-1 protein expression
pattern overall showed a similar
pattern to VEGF, i.e., decreased
steadily between 0 and 48 h PP
(*p value=0.008). β actin was
used as the normalizer. n=5
of this phase of CR is potentially vital as it may improve our
understanding of obstetrical complications that may be asso-
ciated with this period, such as cervicitis, ectropion, hemor-
rhage, repeated miscarriages or abortions and, possibly, pre-
term labor and malignancies (Fahmy et al. 1991). The present
study is the first comprehensive postpartum study and uses a
variety of techniques to examine the morphological and mo-
lecular changes in the mouse cervix during the first 48 h of
postpartum. The key findings of the present data are: (1) epi-
thelial folds and cervical size progressively diminish during
postpartum repair, (2) HIF-1α, VEGF, and VEGFR-1 expres-
sion are pronounced early in postpartum cervical repair, and
(3) VEGFR-2 gene and protein expressions are variable.
The current SEM data show the presence of cervical epi-
thelial folds at 0 h postpartum. These findings are consistent
with our most recent work that utilized SEM and
bromodeoxyuridine (BrdU) staining showing cervical epithe-
lial proliferation leading up to parturition, as well as in non-
pregnant ovariectomized mice that were treated with exoge-
nous VEGF (Mowa et al. 2008b; Donnelly et al. 2013). Of
Fig. 5 Chronological cellular
expression pattern of VEGF in
postpartum mouse cervix, as
revealed by confocal
immunofluorescence. VEGF
immune-expression was initially
concentrated in cervical epithelia
cells (b, b’, 0 h), spreading later to
the other cell types (stromal) (c,
8 h) and diminishing in intensity
by 24 h and thereafter (d–f). The
sections were stained with VEGF
Texas red antibodies and a nuclei-
specific stain, i.e., Sytox Green™,
which stains green. The overlap
between the two appears as
yellow. n=1
interest, cervical tissue, as seen at low (×50) magnification, is
clearly greater in size at 0 h compared to 48 h postpartum,
which again is consistent with cell proliferation leading up to
parturition, and postpartum recovery back to a non-pregnant
state. The exact identity of the substance covering the epithe-
lial cells, appearing at 24 h postpartum, is unclear. It is possi-
ble that it could be derived from ECM, cervical mucus, or
cellular debris. These observations and suggestions are con-
sistent with previous reports that suggest postpartum repair
may involve both clearance and synthesis of ECM molecules
(Timmons et al. 2010), which may explain why in the present
study the substance was only seen at 24 h postpartum, but not
at 0 and 48 h postpartum. Using H&E staining, we were able
to see changes within the cervical epithelium, mucosa, and
other intracellular structures, as well as the ECM. H&E stain-
ing studies also confirmed both the folded convoluted nature
of the cervical epithelium at 0 h postpartum and the covering
substance at 24 h postpartum, revealed by SEM. Also, the
presence of cellular nuclei in the covering substance suggests
that it could be cellular debris. However, it is also possible that
there could be ECM molecules and/or cervical mucus in the
covering substance.
We have previously characterized the expression profile of
HIF-1α (preliminary data) as well as VEGF and its receptors,
VEGFR-1 and VEGFR-2 (Mowa et al. 2004, 2008b;
Donnelly et al. 2013) in pre-partum and 2 days postpartum
rodent cervix. Here, we sought to determine their chronolog-
ical expression profile postpartum at different time points be-
tween parturition and 48 h postpartum in order to determine
whether they have a temporal relationship with and, ultimate-
ly, have a role in postpartum cervical repair. Of interest, levels
of HIF-1α, VEGF, and VEGFR-1 (gene and protein) were
found to be elevated in early postpartum and decreased to their
lowest levels by 48 h postpartum, a pattern that was similar to
the genome-wide expression pattern of proteins associated
with pro-inflammatory and wound healing, revealed in our
preliminary proteomics analysis (data not shown). Since
HIF-1α is ultra-sensitive to changes in intracellular oxygen
concentration, i.e., is rapidly degraded under normoxic condi-
tions (Semenza 2004), but activated and stabilized under hyp-
oxic conditions (Majmundar et al. 2010; Semenza 2004), its
local tissue concentrations can therefore be used to indirectly
measure the degree of local oxygen concentrations. Thus, el-
evated gene and protein expression of HIF-1α observed at 0 h
Fig. 6 Chronological cellular
expression pattern of HIF-1α
protein in postpartum (PP) mouse
cervix, as revealed by confocal
immunofluorescence. HIF-1α
fluorescence was localized in all
cell types, notably epithelial (E)
and stromal cells, with a spike of
expression at 8 h PP particularly
in stromal cells (red fluorescence)
and diminished at 16, 40 and the
lowest expression by 48 h PP. The
sections were stained with HIF-
1α Texas red antibodies and a
nuclei-specific stain, i.e., Sytox
Green™, which stains green. A
moderate overlap between the
two appears as yellow, with a
strong HIF-1α staining appearing
as red. L lumen. n=1
postpartum, in the cervix in the present study, suggests the
presence of a hypoxic state. Under such conditions (hypoxic),
HIF-1α, overall, induces transcription of a range of genes that
promote angiogenesis and cell survival, notably VEGF, but
also including: metabolic enzymes, cytokines, growth factors,
cytoskeletal proteins, and ECM molecules (Majmundar et al.
2010; Semenza 2004). Indeed, HIF-1α is the most potent
inducer of VEGF (Majmundar et al. 2010), the key angiogenic
molecule, which is also intricately linked to inflammation in a
variety of tissue types, including the cervix (Nguyen et al.
2012;Mowa et al. 2008b), as well as wound healing in general
(Galiano et al. 2004; Mowa et al. 2008a; Alberts et al. 2008;
Bao et al. 2009; Eming and Krieg 2006).
While the pattern of HIF-1α, VEGF, and VEGFR-1 gene/
protein expressions were in agreement, it was not so with
VEGFR-2 gene and protein expression. Real-time PCR dem-
onstrated a decrease in mRNA expression of VEGFR-2 be-
tween 0 and 48 h postpartum. However, protein levels of
VEGFR-2 steadily increased, peaking between 40 and 48 h
postpartum, as revealed by both Western blot and confocal
immunofluorescence. It is likely that the turnover of
VEGFR-2 transcript is higher (more unstable) than protein.
VEGFR-2 is known to mediate most biological effects of
VEGF, including mitogenic, angiogenic, and cell survival
properties (Ge et al. 2012), whereas, although VEGFR-1 has
a higher affinity for VEGF, it has weak tyrosine phosphoryla-
tion activity compared to VEGFR-2 (Roskoski 2007), and,
therefore, is of less functional significance. Further, the
VEGFR-1 transcript can undergo alternative splicing that gen-
erates a soluble VEGFR-1 that acts to suppress the effects of
VEGF (Roskoski 2007; Stuttfield and Ballmer-Hofer 2009).
However, VEGFR-1 is known to play a role in cell migration
(Roskoski 2007), and in certain cells that express VEGFR-1,
such as blood platelets, macrophages, and neutrophils, and
Flt-1 also mediates their chemotactic response to VEGF
during wound healing (Bao et al. 2009; Eming and Krieg
2006). Based on these facts, and taking into account the
difference of VEGF receptors in biochemical properties, it
is likely that VEGFR-1 mediates VEGF processes asso-
ciated with early hours of postpartum cervical repair, such
as immune-related and wound-healing functions, while
VEGFR-2 mediates the latter part of postpartum repair
and VEGF, and perhaps functions such as cell survival
and angiogenesis. Collectively, these processes restore
Fig. 7 Chronological cellular
expression of Flt-1 protein in the
postpartum mouse cervix, as
revealed by confocal
immunofluorescence. Overall,
Flt-1 protein expression was
diffusely localized in both the
epithelial (E) and stromal cells
stained. However, a more
pronounced expression was
largely localized in the epithelia,
and overall, a weaker signal was
observed in the cells between 40
and 48 h. The tissue was
incubated with Flt-1 Texas red
antibodies, and a nuclei-specific
stain, i.e., Sytox Green™, which
stains green. Any overlap
between the two appears as
yellow, with a strong Flt-1
appearing as red. L lumen. n=1
the cervix back to its non-pregnant state. Future functional
studies are needed to test these speculations.
Hypoxia is known to be involved in various physiological
and/or pathological responses, but may also play a role in
parturition. For instance, in the high altitude mountain ranges
of the Andes, expectant mothers are believed to induce child-
birth at term by climbing to high elevations with a lower
oxygen environment or hypoxia. Similarly, it is likely that
hypoxia could account for the increased risk in preterm labor
associated with smoking. Interestingly, our recent preliminary
proteomics data revealed two hypoxia-induced proteins that
were highly expressed at 0 h postpartum. Transgelin is an
actin-crosslinking protein known to be expressed in fibro-
blasts and smooth muscle (Kim et al. 2009, 2012), and is
strongly expressed in both the uterus and cervix. Recent
studies by Kim et al. (2012) demonstrated that transgelin is
up-regulated by hypoxia, independent of HIF-1α, and also
activates the insulin-like growth factor receptor 1 (IGFR1)
signaling pathway under hypoxic stress. The IGFR1 pathway
has recently been shown to promote cell survival under hyp-
oxic stress (Kim et al. 2012; Gariboldi et al. 2010) by up-
regulating HIF-1α gene transcription (Gariboldi et al. 2010)
and stabilizing HIF-1α protein (Piecewicz et al. 2012). This
up-regulation and stabilization of HIF-1α by the IGFR1 axis
has been shown to induce VEGF expression during embryon-
ic vasculogenesis (Piecewicz et al. 2012), and angiogenesis in
malignant tumor cells under hypoxic stress (Gariboldi et al.
2010). Whether transgelin acts upstream of HIF-1α and
VEGF in postpartum cervical repair is for now speculative.
Like transgelin, vimentin has also been associated with hyp-
oxia. For instance, it has been shown to redistribute among the
endothelial cell into stable structures in response to hypoxia
(Lui et al. 2010), is involved in general wound healing (Rogel
et al. 2011), and is known to play a role in migrating cells,
including fibroblasts, macrophages, endothelial cells, and in-
vasive cancer cells (Lui et al. 2010; Rogel et al. 2011; Hefland
et al. 2011; Glaser-Gabay et al. 2011). Further studies are
needed to examine the roles of these hypoxia-induced proteins
in the postpartum phase of cervical remodeling. Postpartum
repair has been previously characterized as a proinflammatory
and wound-healing process (Timmons and Mahendroo 2007;
Bauer et al. 2009; Gonzalez et al. 2009). Our current data of
postpartum cervical tissue are consistent with the earlier
studies.
Fig. 8 Chronological cellular
expression pattern of VEGFR-2
protein in the postpartum mouse
cervix, as revealed by confocal
immunofluorescence. Overall, the
signal of VEGFR-2 staining
increased over time, particularly
from 16 h postpartum in epithelia
(E) and stromal cells, with the
weakest signal appearing between
0–8 h and slightly diminishing at
48 h. The tissue was incubated
with VEGFR-2 Texas red
antibodies, and a nuclei-specific
stain, i.e., Sytox Green™, which
stains green. Any overlap
between the two appears as
yellow, with a strong VEGFR-2
signal appearing as red. L lumen.
n=1
In summary, our data provide the first expression profile of
VEGF, its receptors (Flt-1 and VEGFR-2), and HIF-1α and
link their pattern of expression to hypoxia-related proteins and
morphological changes. The limitation of the current study
includes small sample size and lack of a detailed immuno-
chemical evaluation of angiogenic factors, particularly
markers of angiogenesis, such as endothelial markers.
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